Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 6 of 6 for “"Neuroprotective action"”.

  1. Molecular mechanism of Abeta recognition and neuroprotection by the glycoconjugate beta-sheet-breaker peptide Ac-LPFFD-Th

    … mechanisms underlying the antifibrillogenic and neuroprotective action exhibited by a new class of trehalose conjugated pentapeptides. Trehalose (Th), a non-reducing disaccharide of alpha-(D)glucose, has been demonstrated to be effective in preventing the aggregation of several proteins. We …

    catania Repository record for Molecular mechanism of Abeta recognition and neuroprotection by the glycoconjugate beta-sheet-breaker peptide Ac-LPFFD-Th (opens in a new tab)

  2. Investigations into the Neuroprotective Effects of Osteopontin in In Vitro and In Vivo Models of Parkinsons Disease

    … of PD. This effect may be mediated through interactions between the RGD binding domain of OPN and integrin receptors resulting in an attenuation of reactive gliosis and the production glial-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF). Therefore, the aim of …

    kings Repository record for Investigations into the Neuroprotective Effects of Osteopontin in In Vitro and In Vivo Models of Parkinsons Disease (opens in a new tab)

  3. Cellular Effects of Cerebral Ischaemia In Vitro’. Cerebroprotective Actions of GABAmimetic agents

    … in the glutamate efflux and also to study the actions of selected GABAmimetics in order to explain why some GABAmimetic agents are neuroprotective but others are not. In parallel electrophysiological studies, the actions of clomethiazole were analysed further. Incubating rat cortical prisms in …

    de-montfort Repository record for Cellular Effects of Cerebral Ischaemia In Vitro’. Cerebroprotective Actions of GABAmimetic agents (opens in a new tab)

  4. Non-invasive drug delivery to the posterior segment of the eye: Development of formulation strategies and evaluation of ocular distribution and pharmacological activity

    … model, HT levels were maintained above the neuroprotective and antiinflammatory IC50 levels for upto 6 h. We also prepared HT loaded (0.1% w/v) solid lipid nanoparticles (SLN’s) using a combination of 85% glyceryl monostereate and 15% compritol ATO 888. The particle size, zeta potential and …

    mississippi Repository record for Non-invasive drug delivery to the posterior segment of the eye: Development of formulation strategies and evaluation of ocular distribution and pharmacological activity (opens in a new tab)